中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Volume 40 Issue 6
Jun.  2024
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(6): 1076-1081

Pathological diagnosis of alcoholic liver disease

DOI: 10.12449/JCH240602

  • Department of Pathology，Mengchao Hepatobiliary Hospital of Fujian Medical University；Diagnostic Pathology Center，Fujian Medical University，Fuzhou 350025，China

More Information
  • Corresponding author: WANG Bin， doctorwang2001@163.com （ORCID： 0000-0003-4504-3752）
  • Received Date: 2024-04-02
  • Accepted Date: 2024-05-14
  • Published Date: 2024-06-25
    Abstract
  • Alcoholic liver disease （ALD） is a liver disease caused by long-term heavy drinking. With the improvement in the living standard of Chinese people， the incidence rate of ALD tends to increase significantly. The typical pathological patterns of ALD include alcoholic steatosis， alcoholic steatohepatitis， liver fibrosis， and alcoholic cirrhosis. The diverse and complex pathological morphology of ALD and its similarities with other liver diseases pose a great challenge to pathologists. This article reviews the histopathological morphology， grading and staging systems， and differential diagnosis of ALD.

     

    • FullText(HTML)
    • References(53)
  • [1]
    National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for alcoholic liver disease: a 2018 update[J]. J Clin Hepatol, 2018, 34( 5): 939- 946. DOI: 10.3969/j.issn.1001-5256.2018.05.006.

    中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 酒精性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34( 5): 939- 946. DOI: 10.3969/j.issn.1001-5256.2018.05.006.
    [2]
    YANG S, XING HC, CHENG J. Comparison and interpretation of Chinese, American, and European guidelines on alcoholic liver diseases[J]. J Clin Hepatol, 2018, 34( 7): 1420- 1422. DOI: 10.3969/j.issn.1001-5256.2018.07.011.

    杨松, 邢卉春, 成军. 中美欧酒精性肝病相关指南的对比与解读[J]. 临床肝胆病杂志, 2018, 34( 7): 1420- 1422. DOI: 10.3969/j.issn.1001-5256.2018.07.011.
    [3]
    BEDOSSA P. Current histological classification of NAFLD: Strength and limitations[J]. Hepatol Int, 2013, 7( Suppl 2): 765- 770. DOI: 10.1007/s12072-013-9446-z.
    [4]
    BRUNT EM. Surgical assessment of significant steatosis in donor livers: The beginning of the end for frozen-section analysis?[J]. Liver Transpl, 2013, 19( 4): 360- 361. DOI: 10.1002/lt.23609.
    [5]
    DENK H, STUMPTNER C, ZATLOUKAL K. Mallory bodies revisited[J]. J Hepatol, 2000, 32( 4): 689- 702. DOI: 10.1016/s0168-8278(00)80233-0.
    [6]
    STRNAD P, ZATLOUKAL K, STUMPTNER C, et al. Mallory-Denk-bodies: Lessons from keratin-containing hepatic inclusion bodies[J]. Biochim Biophys Acta, 2008, 1782( 12): 764- 774. DOI: 10.1016/j.bbadis.2008.08.008.
    [7]
    ROBERTSON NJ, KENDALL CH. Liver giant mitochondria revisited[J]. J Clin Pathol, 1992, 45( 5): 412- 415. DOI: 10.1136/jcp.45.5.412.
    [8]
    BRUGUERA M, BERTRAN A, BOMBI JA, et al. Giant mitochondria in hepatocytes: A diagnostic hint for alcoholic liver disease[J]. Gastroenterology, 1977, 73( 6): 1383- 1387.
    [9]
    TELI MR, DAY CP, BURT AD, et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver[J]. Lancet, 1995, 346( 8981): 987- 990. DOI: 10.1016/s0140-6736(95)91685-7.
    [10]
    JAESCHKE H. Neutrophil-mediated tissue injury in alcoholic hepatitis[J]. Alcohol, 2002, 27( 1): 23- 27. DOI: 10.1016/s0741-8329(02)00200-8.
    [11]
    RAMAIAH SK, JAESCHKE H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury[J]. Toxicol Pathol, 2007, 35( 6): 757- 766. DOI: 10.1080/01926230701584163.
    [12]
    MA J, GUILLOT A, YANG ZH, et al. Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failure[J]. J Clin Invest, 2022, 132( 14): e157780. DOI: 10.1172/JCI157780.
    [13]
    BATALLER R, ARAB JP, SHAH VH. Alcohol-associated hepatitis[J]. N Engl J Med, 2022, 387( 26): 2436- 2448. DOI: 10.1056/NEJMra2207599.
    [14]
    ROTH NC, QIN J. Histopathology of alcohol-related liver diseases[J]. Clin Liver Dis, 2019, 23( 1): 11- 23. DOI: 10.1016/j.cld.2018.09.001.
    [15]
    MATHURIN P, BEUZIN F, LOUVET A, et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features[J]. Aliment Pharmacol Ther, 2007, 25( 9): 1047- 1054. DOI: 10.1111/j.1365-2036.2007.03302.x.
    [16]
    WANLESS IR, SHIOTA K. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: A four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis[J]. Semin Liver Dis, 2004, 24( 1): 99- 106. DOI: 10.1055/s-2004-823104.
    [17]
    AIGELSREITER A, JANIG E, SOSTARIC J, et al. Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis[J]. Histopathology, 2009, 54( 5): 561- 570. DOI: 10.1111/j.1365-2559.2009.03258.x.
    [18]
    NAKANO M, WORNER TM, LIEBER CS. Perivenular fibrosis in alcoholic liver injury: Ultrastructure and histologic progression[J]. Gastroenterology, 1982, 83( 4): 777- 785.
    [19]
    van WAES L, LIEBER CS. Early perivenular sclerosis in alcoholic fatty liver: An index of progressive liver injury[J]. Gastroenterology, 1977, 73( 4 Pt 1): 646- 650.
    [20]
    EDMONDSON HA, PETERS RL, REYNOLDS TB, et al. Sclerosing hyaline necrosis of the liver in the chronic alcoholic. A recognizable clinical syndrome[J]. Ann Intern Med, 1963, 59: 646- 673. DOI: 10.7326/0003-4819-59-5-646.
    [21]
    FLEMING KA, MCGEE JO. Alcohol induced liver disease[J]. J Clin Pathol, 1984, 37( 7): 721- 733. DOI: 10.1136/jcp.37.7.721.
    [22]
    COLOMBAT M, CHARLOTTE F, RATZIU V, et al. Portal lymphocytic infiltrate in alcoholic liver disease[J]. Hum Pathol, 2002, 33( 12): 1170- 1174. DOI: 10.1053/hupa.2002.129414.
    [23]
    ROSKAMS T, DESMET V. Ductular reaction and its diagnostic significance[J]. Semin Diagn Pathol, 1998, 15( 4): 259- 269.
    [24]
    MORGAN MY, SHERLOCK S, SCHEUER PJ. Portal fibrosis in the livers of alcoholic patients[J]. Gut, 1978, 19( 11): 1015- 1021. DOI: 10.1136/gut.19.11.1015.
    [25]
    PHILLIPS GB, DAVIDSON CS. Liver disease of the chronic alcoholic simulating extrahepatic biliary obstruction[J]. Gastroenterology, 1957, 33( 2): 236- 244.
    [26]
    BRUNT EM. Nonalcoholic steatohepatitis: Definition and pathology[J]. Semin Liver Dis, 2001, 21( 1): 3- 16. DOI: 10.1055/s-2001-12925.
    [27]
    KATOONIZADEH A, LALEMAN W, VERSLYPE C, et al. Early features of acute-on-chronic alcoholic liver failure: A prospective cohort study[J]. Gut, 2010, 59( 11): 1561- 1569. DOI: 10.1136/gut.2009.189639.
    [28]
    BONAL M, MOURAD M, BANCEL B, et al. Cholangitis lenta: An underdiagnosed lesion associated with severe cholestasis following liver transplantation[J]. Clin Transplant, 2020, 34( 9): e14016. DOI: 10.1111/ctr.14016.
    [29]
    YAMADA S, TAKEZAWA J, TAKAGI H, et al. Histologic features and bile duct lesions in the alcoholic[J]. Jpn J Med, 1985, 24( 3): 223- 230. DOI: 10.2169/internalmedicine1962.24.223.
    [30]
    ZIMMER V, BITTENBRING J, FRIES P, et al. Severe mixed-type iron overload in alcoholic cirrhosis related to advanced spur cell anemia[J]. Ann Hepatol, 2014, 13( 3): 396- 398.
    [31]
    LI LX, GUO FF, LIU H, et al. Iron overload in alcoholic liver disease: Underlying mechanisms, detrimental effects, and potential therapeutic targets[J]. Cell Mol Life Sci, 2022, 79( 4): 201. DOI: 10.1007/s00018-022-04239-9.
    [32]
    COSTA MATOS L, BATISTA P, MONTEIRO N, et al. Iron stores assessment in alcoholic liver disease[J]. Scand J Gastroenterol, 2013, 48( 6): 712- 718. DOI: 10.3109/00365521.2013.781217.
    [33]
    NAHON P, SUTTON A, RUFAT P, et al. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis[J]. Gastroenterology, 2008, 134( 1): 102- 110. DOI: 10.1053/j.gastro.2007.10.038.
    [34]
    YIP WW, BURT AD. Alcoholic liver disease[J]. Semin Diagn Pathol, 2006, 23( 3-4): 149- 160. DOI: 10.1053/j.semdp.2006.11.002.
    [35]
    SUZUKI Y, YOKOYAMA A, NAKANO M, et al. Cyanamide-induced liver dysfunction after abstinence in alcoholics: A long-term follow-up study on four cases[J]. Alcohol Clin Exp Res, 2000, 24( 4 Suppl): 100S- 105S.
    [36]
    TANJI K, BHAGAT G, VU TH, et al. Mitochondrial DNA dysfunction in oncocytic hepatocytes[J]. Liver Int, 2003, 23( 5): 397- 403. DOI: 10.1034/j.1478-3231.2003.00864.x.
    [37]
    HUANG DQ, MATHURIN P, CORTEZ-PINTO H, et al. Global epidemiology of alcohol-associated cirrhosis and HCC: Trends, projections and risk factors[J]. Nat Rev Gastroenterol Hepatol, 2023, 20( 1): 37- 49. DOI: 10.1038/s41575-022-00688-6.
    [38]
    HUANG DQ, TAN DJH, NG CH, et al. Hepatocellular carcinoma incidence in alcohol-associated cirrhosis: Systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2023, 21( 5): 1169- 1177. DOI: 10.1016/j.cgh.2022.06.032.
    [39]
    TERASAKI S, KANEKO S, KOBAYASHI K, et al. Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: A prospective study[J]. Gastroenterology, 1998, 115( 5): 1216- 1222. DOI: 10.1016/s0016-5085(98)70093-9.
    [40]
    DELEMOS A, PATEL M, GAWRIEH S, et al. Distinctive features and outcomes of hepatocellular carcinoma in patients with alcohol-related liver disease: A US multicenter study[J]. Clin Transl Gastroenterol, 2020, 11( 3): e00139. DOI: 10.14309/ctg.0000000000000139.
    [41]
    LACKNER C, STAUBER RE, DAVIES S, et al. Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease[J]. J Hepatol, 2021, 75( 4): 810- 819. DOI: 10.1016/j.jhep.2021.05.029.
    [42]
    PATEL V, SANYAL AJ. Drug-induced steatohepatitis[J]. Clin Liver Dis, 2013, 17( 4): 533- 546, vii. DOI: 10.1016/j.cld.2013.07.012.
    [43]
    RAMANATHAN R, IBDAH JA. Mitochondrial dysfunction and acute fatty liver of pregnancy[J]. Int J Mol Sci, 2022, 23( 7): 3595. DOI: 10.3390/ijms23073595.
    [44]
    KAYAÇETIN S, BAŞARANOĞLU M. Mallory-Denk bodies: Correlation with steatosis, severity, zonal distribution, and identification with ubiquitin[J]. Turk J Gastroenterol, 2015, 26( 6): 506- 510. DOI: 10.5152/tjg.2015.150199.
    [45]
    BASARANOGLU M, TURHAN N, SONSUZ A, et al. Mallory-Denk Bodies in chronic hepatitis[J]. World J Gastroenterol, 2011, 17( 17): 2172- 2177. DOI: 10.3748/wjg.v17.i17.2172.
    [46]
    GONZÁLEZ IA, FULLER LD, ZHANG XF, et al. Development of a scoring system to differentiate amiodarone-induced liver injury from alcoholic steatohepatitis[J]. Am J Clin Pathol, 2022, 157( 3): 434- 442. DOI: 10.1093/ajcp/aqab142.
    [47]
    OLIVEIRA THC, MARQUES PE, PROOST P, et al. Neutrophils: A cornerstone of liver ischemia and reperfusion injury[J]. Lab Invest, 2018, 98( 1): 51- 62. DOI: 10.1038/labinvest.2017.90.
    [48]
    VANSTAPEL MJ, DESMET VJ. Cytomegalovirus hepatitis: A histological and immunohistochemical study[J]. Appl Pathol, 1983, 1( 1): 41- 49.
    [49]
    TUNG BY, Jr CARITHERS RL. Cholestasis and alcoholic liver disease[J]. Clin Liver Dis, 1999, 3( 3): 585- 601. DOI: 10.1016/s1089-3261(05)70086-6.
    [50]
    STEWART RV, DINCSOY HP. The significance of giant mitochondria in liver biopsies as observed by light microscopy[J]. Am J Clin Pathol, 1982, 78( 3): 293- 298. DOI: 10.1093/ajcp/78.3.293.
    [51]
    SAKHUJA P. Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?[J]. World J Gastroenterol, 2014, 20( 44): 16474- 16479. DOI: 10.3748/wjg.v20.i44.16474.
    [52]
    YEH MM, BRUNT EM. Pathological features of fatty liver disease[J]. Gastroenterology, 2014, 147( 4): 754- 764. DOI: 10.1053/j.gastro.2014.07.056.
    [53]
    DIEHL AM, GOODMAN Z, ISHAK KG. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury[J]. Gastroenterology, 1988, 95( 4): 1056- 1062.
    • Relative Articles

  • Relative Articles

    [1]Xiaodong TENG. Value of biopsy in evaluating the pathological progression of autoimmune hepatitis/pancreatitis[J]. Journal of Clinical Hepatology, 2024, 40(6): 1073-1075. doi: 10.12449/JCH240601
    [2]Wenjun YANG. Pathological diagnosis of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2024, 40(6): 1082-1087. doi: 10.12449/JCH240603
    [3]Qiupeng WANG, Meifu GAN. Pathological diagnosis of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2024, 40(6): 1088-1092. doi: 10.12449/JCH240604
    [4]Jiping ZHANG. Pathological diagnosis of cholestatic liver disease[J]. Journal of Clinical Hepatology, 2024, 40(6): 1093-1099. doi: 10.12449/JCH240605
    [5]Ke SUN. Pathological diagnosis of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2024, 40(6): 1100-1106. doi: 10.12449/JCH240606
    [6]Aiping TIAN, Yongfeng YANG. Diagnosis of nonalcoholic fatty liver disease: The importance of pathology[J]. Journal of Clinical Hepatology, 2023, 39(3): 491-497. doi: 10.3969/j.issn.1001-5256.2023.03.002
    [7]Yu ZHANG, Yongfeng YANG. Thinking of the pathological diagnosis of unexplained liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(3): 498-503. doi: 10.3969/j.issn.1001-5256.2023.03.003
    [8]Mengmeng ZHANG, Yao MENG, Xinyan ZHAO. Differential pathological diagnosis of liver tissue with normal appearance[J]. Journal of Clinical Hepatology, 2023, 39(3): 517-522. doi: 10.3969/j.issn.1001-5256.2023.03.006
    [9]Xinhang SONG, Juanhan YU, Zhaoping CHENG, Chen SHAO, Baocheng DENG. Pathological staging systems of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2022, 38(3): 653-655. doi: 10.3969/j.issn.1001-5256.2022.03.033
    [10]Miao Qi, Chen XiaoYu. Liver histopathological diagnosis of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 728-730. doi: 10.3969/j.issn.1001-5256.2020.04.003
    [11]Jiao DeChao, Lei QinYu, Han XinWei, Li ZongMing, Bi YongHua, Zhang QuanHui. Clinical value of ultra-thin electronic flexible endoscopy combined with intraluminal ultrasound in assisting percutaneous transhepatic biliary stricture biopsy[J]. Journal of Clinical Hepatology, 2019, 35(12): 2744-2747. doi: 10.3969/j.issn.1001-5256.2019.12.021
    [12]Yang YongFeng. Improve the knowledge of liver pathology and related skills among clinicians engaged in hepatology[J]. Journal of Clinical Hepatology, 2018, 34(11): 2267-2270. doi: 10.3969/j.issn.1001-5256.2018.11.001
    [13]Tian AiPing, Yang YongFeng. A comparative analysis of pathological grading and staging systems for chronic hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2271-2277. doi: 10.3969/j.issn.1001-5256.2018.11.002
    [14]Luo WenPing, Ma Hong, Zhao XinYan. Pathological features of hepatic vascular diseases and key points in differential diagnosis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2289-2294. doi: 10.3969/j.issn.1001-5256.2018.11.005
    [15]Jiang LiLin, Shen JianBo, Tang Hong, Lu ZhongHua. Pathological differential diagnosis of inflammatory liver injury[J]. Journal of Clinical Hepatology, 2018, 34(11): 2278-2282. doi: 10.3969/j.issn.1001-5256.2018.11.003
    [16]Wu DongBo, Chen EnQiang, Bai Lang, Tang Hong. Liver biopsy and related techniques in pathological diagnosis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2295-2299. doi: 10.3969/j.issn.1001-5256.2018.11.006
    [17]Chinese Society of Liver Cancer, Chinese Anti-Cancer Association, Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Pathology, Chinese Anti-Cancer Association, Digestive Disease Group, Chinese Society of Pathology, Chinese Medical Association, epatic Surgery Group, Chinese Society of Surgery, Chinese Medical Association, Chinese Society of Clinical Oncology, Chinese Anti-Cancer Association, Chinese Pathological Group of Hepatobiliary Tumor and Liver Transplantation. Evidence-based practice guidelines for the standardized pathological diagnosis of primary liver cancer in China( 2015 update)[J]. Journal of Clinical Hepatology, 2015, 31(6): 833-839. doi: 10.3969/j.issn.1001-5256.2015.06.004
    [18]Shi MeiJie, Zhang ChaoZhen, Chi XiaoLing, Xie YuBao, Xiao HuanMing. Analysis of clinical high-risk factors for hepatitis B cirrhosis confirmed by liver biopsy[J]. Journal of Clinical Hepatology, 2014, 30(2): 149-152. doi: 10.3969/j.issn.1001-5256.2014.02.013
    [19]Lang ZhenWei. Pathological advances in autoimmune liver disease[J]. Journal of Clinical Hepatology, 2012, 28(5): 326-331.
    [20]Ni Wei, Shi WeiQun. Clinical diagnosis and liver biopsy diagnosis of 97 cases with chronic HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(6): 623-624+637.
    • Supplements(0)
    • Cited By

  • Cited by

    Periodical cited type(1)

    1. 苏桐，刘柳，吕秦川，张洵铭，郝林琳，吕岩，宋青龙. 牛骨胶原蛋白肽酒制备及对小鼠酒后肝损伤的保护作用. 吉林农业大学学报. 2024(06): 1074-1080 .

    Other cited types(0)

  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 20.1 %FULLTEXT: 20.1 %META: 67.8 %META: 67.8 %PDF: 12.1 %PDF: 12.1 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 8.8 %其他: 8.8 %其他: 0.4 %其他: 0.4 %Russian Federation: 0.1 %Russian Federation: 0.1 %Seattle: 0.1 %Seattle: 0.1 %Tiruchi: 0.1 %Tiruchi: 0.1 %上海: 5.9 %上海: 5.9 %上饶: 0.1 %上饶: 0.1 %东莞: 0.1 %东莞: 0.1 %中山: 0.2 %中山: 0.2 %乌鲁木齐: 0.2 %乌鲁木齐: 0.2 %伊万诺沃: 0.1 %伊万诺沃: 0.1 %信阳: 0.2 %信阳: 0.2 %克拉玛依: 0.2 %克拉玛依: 0.2 %兰州: 0.1 %兰州: 0.1 %内江: 0.1 %内江: 0.1 %加利福尼亚州: 0.1 %加利福尼亚州: 0.1 %包头: 0.1 %包头: 0.1 %北京: 6.6 %北京: 6.6 %十堰: 0.2 %十堰: 0.2 %南京: 2.6 %南京: 2.6 %南宁: 0.6 %南宁: 0.6 %南通: 0.1 %南通: 0.1 %卡纳塔克: 0.2 %卡纳塔克: 0.2 %厦门: 0.5 %厦门: 0.5 %台北: 0.2 %台北: 0.2 %台州: 0.1 %台州: 0.1 %合肥: 0.6 %合肥: 0.6 %吉林: 0.4 %吉林: 0.4 %呼伦贝尔: 0.1 %呼伦贝尔: 0.1 %呼和浩特: 0.2 %呼和浩特: 0.2 %咸宁: 0.1 %咸宁: 0.1 %咸阳: 0.3 %咸阳: 0.3 %哈尔滨: 0.1 %哈尔滨: 0.1 %哥伦布: 0.2 %哥伦布: 0.2 %唐山: 0.2 %唐山: 0.2 %喀什: 0.1 %喀什: 0.1 %圣安东尼奥: 0.1 %圣安东尼奥: 0.1 %大连: 0.7 %大连: 0.7 %天津: 0.1 %天津: 0.1 %太原: 0.3 %太原: 0.3 %娄底: 0.2 %娄底: 0.2 %孟买: 0.3 %孟买: 0.3 %宁波: 0.1 %宁波: 0.1 %安娜堡: 0.3 %安娜堡: 0.3 %安康: 0.4 %安康: 0.4 %宜兰: 0.1 %宜兰: 0.1 %宜春: 0.1 %宜春: 0.1 %宝鸡: 0.1 %宝鸡: 0.1 %宣城: 0.3 %宣城: 0.3 %巴音郭楞: 0.5 %巴音郭楞: 0.5 %常州: 0.2 %常州: 0.2 %常德: 0.3 %常德: 0.3 %平顶山: 0.2 %平顶山: 0.2 %广州: 1.3 %广州: 1.3 %张家口: 4.6 %张家口: 4.6 %意法半: 0.2 %意法半: 0.2 %成都: 0.9 %成都: 0.9 %抚顺: 0.2 %抚顺: 0.2 %新乡: 0.2 %新乡: 0.2 %无锡: 0.3 %无锡: 0.3 %昆明: 2.5 %昆明: 2.5 %昌都: 0.2 %昌都: 0.2 %杭州: 1.8 %杭州: 1.8 %桂林: 0.1 %桂林: 0.1 %武汉: 0.1 %武汉: 0.1 %沈阳: 1.3 %沈阳: 1.3 %沧州: 0.1 %沧州: 0.1 %泽西: 0.1 %泽西: 0.1 %济南: 0.5 %济南: 0.5 %海得拉巴: 0.2 %海得拉巴: 0.2 %深圳: 0.1 %深圳: 0.1 %温州: 0.1 %温州: 0.1 %湘潭: 0.1 %湘潭: 0.1 %湛江: 0.6 %湛江: 0.6 %漯河: 0.4 %漯河: 0.4 %潍坊: 0.1 %潍坊: 0.1 %焦作: 0.4 %焦作: 0.4 %玉溪: 0.1 %玉溪: 0.1 %盐城: 0.1 %盐城: 0.1 %眉山: 0.1 %眉山: 0.1 %石家庄: 0.4 %石家庄: 0.4 %福州: 0.4 %福州: 0.4 %科泽科德: 0.1 %科泽科德: 0.1 %绍兴: 0.2 %绍兴: 0.2 %聊城: 0.4 %聊城: 0.4 %芒廷维尤: 21.4 %芒廷维尤: 21.4 %芝加哥: 2.0 %芝加哥: 2.0 %苏州: 0.3 %苏州: 0.3 %莫斯科: 0.4 %莫斯科: 0.4 %萍乡: 0.1 %萍乡: 0.1 %衡阳: 0.6 %衡阳: 0.6 %西宁: 9.5 %西宁: 9.5 %西安: 1.5 %西安: 1.5 %西雅图: 0.1 %西雅图: 0.1 %诺沃克: 0.3 %诺沃克: 0.3 %贝塞斯达: 0.1 %贝塞斯达: 0.1 %贵阳: 0.3 %贵阳: 0.3 %运城: 0.6 %运城: 0.6 %遵义: 0.5 %遵义: 0.5 %邯郸: 0.1 %邯郸: 0.1 %郑州: 0.9 %郑州: 0.9 %重庆: 1.0 %重庆: 1.0 %银川: 0.5 %银川: 0.5 %长春: 6.6 %长春: 6.6 %长沙: 1.1 %长沙: 1.1 %青岛: 0.2 %青岛: 0.2 %黔南: 0.3 %黔南: 0.3 %齐齐哈尔: 0.1 %齐齐哈尔: 0.1 %其他其他Russian FederationSeattleTiruchi上海上饶东莞中山乌鲁木齐伊万诺沃信阳克拉玛依兰州内江加利福尼亚州包头北京十堰南京南宁南通卡纳塔克厦门台北台州合肥吉林呼伦贝尔呼和浩特咸宁咸阳哈尔滨哥伦布唐山喀什圣安东尼奥大连天津太原娄底孟买宁波安娜堡安康宜兰宜春宝鸡宣城巴音郭楞常州常德平顶山广州张家口意法半成都抚顺新乡无锡昆明昌都杭州桂林武汉沈阳沧州泽西济南海得拉巴深圳温州湘潭湛江漯河潍坊焦作玉溪盐城眉山石家庄福州科泽科德绍兴聊城芒廷维尤芝加哥苏州莫斯科萍乡衡阳西宁西安西雅图诺沃克贝塞斯达贵阳运城遵义邯郸郑州重庆银川长春长沙青岛黔南齐齐哈尔

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (733) PDF downloads(130) Cited by(1)
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2695]YesterdayPV[4820]TodayIP[234]TodayPV[555]Online[16]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return